WuXi Biologics

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Using clinical data to drive effective formulation optimisation Conventional approaches to develop and optimise formulations are suboptimal and require extensive pharmaceutical development activities to be undertaken prior to clinical...
  2. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  3. Gerresheimer cooperates with Injecto and launches silicone-oil- and PFAS-free syringe systems Supply and license agreement with Injecto Group for long-term availability of silicone-oil-free plunger stoppers; avoiding silicone-oil significantly reduces particle pollution
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Tariff hikes call for CPOs to keep reputational issues and costs down Time for procurement in the pharmaceutical industry to tap into internal expertise
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Improving ADC selection with AI-enabled assays In this article, Dr Rob Monroe, Chief Medical Officer at Leica Biosystems, discusses how diagnostics companies are working with researchers to develop novel assays leveraging...

Upcoming event

Making Pharmaceuticals

29-30 April 2025 | Conference | Coventry, UK See all

Related Content

Manufacturing

Merck buys WuXi Biologics' Irish vaccine manufacturing facility for $500m

This sale is part of WuXi Biologics' initiative to build business in the face of the BIOSECURE act, as the company places a stronger focus on building its CDMO services in China
Packaging

Schreiner MediPharm develops protective label for light-sensitive ADC on behalf of WuXi XDC

The pharmaceutical labelling company developed a cover for a light/UV-sensitive ADC drug product contained in a vial on behalf of CRDMO WuXi
Manufacturing

WuXi Vaccines wins second consecutive “Best Vaccine CMO Award” at AVEA 2023

WuXi Vaccines, a leading global vaccine contract development and manufacturing organisation (CDMO), was named "Best Vaccine CMO of the Year" for the second consecutive year at the 2023 Asia-Pacific Vaccine Excellence Awards (AVEA) ceremony
Research & Development

Myricx Bio enters into an exclusive antibody license agreement with WuXi Biologics

Myricx Bio and WuXi Biologics have entered into a license agreement under which Myricx will have exclusive access to a proprietary antibody that was discovered based on WuXi Bio’s integrated technology platforms
Manufacturing

WuXi Biologics completes first GMP run at 24,000L line of MFG5 facility

With its total 60,000L capacity, MFG5 has now supported manufacture of late-phase and commercial projects across multiple modalities, such as monoclonal antibodies, bispecifics and fusion proteins
Design & Build

WuXi Biologics closes deal to build biomanufacturing hub in the US

China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
Ingredients

WuXi Biologics and Aravive join forces on high-affinity bispecific antibodies

The collaboration will target cancer and fibrosis and use the WuXiBody Platform
Subscribe now